Bidirectional ventricular tachycardia in cardiac sarcoidosis. by Benjamin, Mina M et al.
UCSF
UC San Francisco Previously Published Works
Title
Bidirectional ventricular tachycardia in cardiac sarcoidosis.
Permalink
https://escholarship.org/uc/item/9d84q16t
Journal
Journal of Arrhythmia, 33(1)
ISSN
1880-4276
Authors
Benjamin, Mina M
Hayes, Kevin
Field, Michael E
et al.
Publication Date
2017-02-01
DOI
10.1016/j.joa.2016.05.003
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Contents lists available at ScienceDirectJournal of Arrhythmia
Journal of Arrhythmia 33 (2017) 69–72http://d
1880-42
(http://c
Abbre
dioverte
tricular
☆N. B
Dr Sche
modifie
n Corr
E-m
kevrhay
Melvin.
khoffmajournal homepage: www.elsevier.com/locate/joaRapid communicationBidirectional ventricular tachycardia in cardiac sarcoidosis$Mina M. Benjamin, MDa,n, Kevin Hayes, MDa, Michael E. Field, MDa, Melvin M. Scheinman, MDb,
Kurt S. Hoffmayer, MDa
a Department of Internal Medicine (Division of Cardiology), University of Wisconsin Hospital and Clinics, 600 Highland Ave, Madison, WI 53713,
United States
b Department of Internal Medicine (Division of Cardiology), University of California in San Francisco, 500 Parnassus Avenue, San Francisco, CA 94143,
United Statesa r t i c l e i n f o
Article history:
Received 30 March 2016
Received in revised form
29 April 2016
Accepted 6 May 2016
Available online 4 June 2016
Keywords:
Ventricular tachycardia
Cardiac sarcoidosis
Arrhythmias
Magnetic resonance tomography
Positron emission tomographyx.doi.org/10.1016/j.joa.2016.05.003
76/& 2016 Japanese Heart Rhythm Society. Pu
reativecommons.org/licenses/by-nc-nd/4.0/).
viations: BVT, Bidirectional ventricular tachyc
r defibrillator; PET, Positron emission tomogr
contraction; VT, Ventricular tachycardia.
. The patient was treated at the Univer
inman was consulted as an expert in the
d the submission.
esponding author. Tel.: þ1 608 263 3041; fax
ail addresses: mmehanni@uwhealth.org (M.M
es@gmail.com (K. Hayes), mefield@medicine.w
Scheinman@ucsf.edu (M.M. Scheinman),
yer@medicine.wisc.edu (K.S. Hoffmayer).a b s t r a c t
A 73-year-old man with history of pulmonary sarcoidosis was found to have runs of non-sustained
bidirectional ventricular tachycardia (BVT) with two different QRS morphologies on a Holter monitor.
Cardiac magnetic resonance delayed gadolinium imaging revealed a region of patchy mid-myocardial
enhancement within the left ventricular basal inferolateral myocardium. An 18-fluorodeoxyglucose
positron emission tomography (FDG-PET) showed increased uptake in the same area, consistent with
active sarcoid, with no septal involvement. Follow-up FDG-PET one year later showed disease progres-
sion with new septal involvement. Cardiac sarcoidosis, characterized by myocardial inflammation and
interstitial fibrosis that can lead to conduction system disturbance and macro re-entrant arrhythmias,
should be considered in differential diagnosis of BVT. BVT may indicate septal involvement with sar-
coidosis before the lesions are large enough to be detected radiologically.
& 2016 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bidirectional ventricular tachycardia (BVT) is defined as a
tachycardia showing beat-to-beat alternation in the QRS axis. The
rate is typically between 140 and 180 bpm, with a frontal plane
axis varying between –20° and 110°. The most common causes of
BVT include catecholaminergic polymorphic ventricular tachy-
cardia and cardiac glycoside toxicity. Other previously described
etiologies include myocarditis, long QT syndrome type 7, con-
genital cardiomyopathies, cardiac tumors, and acute cardiac allo-
graft rejection. Cardiac sarcoidosis is characterized by myocardial
inflammation and interstitial fibrosis that can lead to slowed
conduction and macro re-entrant arrhythmias. We report a case ofblished by Elsevier B.V. This is an
ardia; ICD, Implantable car-
aphy; PVC, Premature ven-
sity of Wisconsin Hospital.
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. Benjamin),
isc.edu (M.E. Field),BVT in a patient with cardiac sarcoidosis and briefly discuss the
proposed mechanisms underlying BVT.2. Case
A 73-year-old man with history of chronic pulmonary sarcoi-
dosis was seen for an annual checkup, during which ventricular
bigeminy was identified on a 12-lead electrocardiogram. Sub-
sequent Holter monitor assessment showed multiple premature
ventricular beats and several short runs of non-sustained ven-
tricular tachycardia (VT), with two different QRS morphologies
(Fig. 1). A cardiac magnetic resonance tomography with delayed
gadolinium showed a curvilinear region of patchy mid-myocardial
enhancement within the inferolateral left ventricular myocardium
near the base, consistent with cardiac sarcoidosis (Fig. 2). The left
and right ventricular ejection fractions were 47% and 37%,
respectively. A nuclear myocardial perfusion study using single-
photon emission computed tomography showed no myocardial
perfusion defects on stress or rest imaging, ruling out ischemia. A
fasting 18-fluorodeoxyglucose positron emission tomography
(PET) demonstrated increased uptake in the same area of the
myocardium that had shown late gadolinium enhancement, con-
sistent with active cardiac sarcoid (Fig. 3A). A one-year follow-up
PET showed disease progression, with new septal involvementopen access article under the CC BY-NC-ND license
Fig. 1. (A) Rhythm strip with leads II and V (nonspecific ventricular), top and bottom, respectively, showing sinus rhythm and a run of ectopic ventricular beats with two
alternating QRS morphologies; the sixth and eighth beats show a left bundle branch block morphology and inferior axis (black X), while the seventh and ninth show a right
bundle branch block morphology and inferior axis (white X). This pattern was seen repeatedly on ambulatory monitoring. Note that the degree of the right bundle branch
block increases during sinus rhythm; the QRS width in the fourth beat is about 120 ms, compared to approximately 160 ms in the fifth beat. A similar phenomenon is also
seen between the tenth and eleventh beats even during a relatively long atrial cycle length of 600 ms. This suggests severe impairment of the conduction system. (B) A 12-
lead electrocardiogram showing sinus rhythm with intraventricular conduction delay, with PVCs in a pattern of ventricular bigeminy. The PVCs resembles a left bundle
branch block pattern with an inferior axis (arrows).
Fig. 2. Delayed enhancement cardiac magnetic resonance tomography with patchy mid-myocardial enhancement in the basal inferolateral left ventricular myocardium
(arrow).
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Fig. 3. Fasting 18-fluorodeoxyglucose (FDG) positron emission tomography at baseline (A) showing increased uptake, most pronounced in the basal inferolateral area of the
myocardium (arrow), consistent with active cardiac sarcoid, and at follow-up (B), showing increased disease progress with FDG uptake in the basal to mid segments of the
anterolateral and basal lateral wall segments as well as new FDG uptake in the basal anteroseptal region.
M.M. Benjamin et al. / Journal of Arrhythmia 33 (2017) 69–72 71(Fig. 3B). The patient was started on immunosuppression therapy
consisting of prednisone and mycophenolate. The patient was
elected to have an implantable cardioverter defibrillator (ICD)
placed for prevention of sudden cardiac death. He had not
experienced any VT episodes during the one-year follow-up.3. Discussion
We describe an additional diagnosis to consider when BVT is
identified. One of the proposed mechanisms of BVT include ele-
vated intracellular calcium, causing delay after depolarization in
anatomically separate parts of the conducting system. Baher et al.
[1] proposed that two separate foci, with different rate thresholds
for delayed after depolarization–induced ventricular bigeminy,
were present in a rabbit model. When the ventricular rate
exceeded the lower threshold, bigeminy would develop. This
would effectively double the heart rate, increasing the overall
ventricular rate above the second threshold. Once this had
developed, the two competing sites would simply alternate on a
beat-to-beat basis. This is likely the mechanism underlying BVT
observed with digitalis toxicity and catecholaminergic poly-
morphic VT. The other proposed mechanisms for BVT include an
alternating bundle branch block related to bifocal automaticity
and inscribed in opposite directions, or scar-mediated reentry
around a circuit with two alternating exit sites. This latter is likely
the underlying mechanism in our case. More recently, Sung et al.
described a mechanism including retrograde conduction over the
mid septal fascicular pathway, with alternating block in the left
anterior or posterior fascicles, to explain polymorphic fascicular
VT patterns [2]. Cardiac sarcoidosis causes ventricular inflam-
mation and scarring due to focal non-caseating granulomas.
Scarring is typically patchy, with a predilection for the basal
septum, anterior wall, and perivalvular regions of the left ven-
tricle. It may also be confluent, affecting the right ventricular
epicardium or endocardium. In sarcoidosis, it is plausible that
multiform or bidirectional premature ventricular contractions
(PVCs) are due to multiple exits from the areas of inflammation
and/or scarring. Conduction disturbances in cardiac sarcoidosis
are not uncommon, and often affect the His-Purkinje system [3].
In our case, the patient had an intraventricular conduction delay
at baseline, with prolonged QRS complexes at relatively low atrial
rates (Fig. 1A). The majority of the retrospective data suggest that
immunosuppression reduces the burden of arrhythmias, espe-
cially in the early phases of the disease [4].Previous case series have reported various success rates with
VT ablation in patients with cardiac sarcoidosis, likely due to the
small number of patients in each series, with varying degrees of
disease burden. The most common circuit for VT in one report was
reentry in the peritricuspid area, which can be safely ablated [5]. In
another study, abolishing all inducible tachycardias was not always
feasible because of septal intramural circuits, extensive right
ventricular scarring, or sites of origin in close proximity to the left
anterior descending, the ramus intermedius arteries, or the para-
Hisian region, which prohibit safe ablation [6]. In the current case,
it is likely that the presence of a septal focus leads to alternate
exits into the right or left ventricle which shows the observed
electrocardiogram pattern. Although the septal involvement was
not visible by imaging until a year after diagnosis, it might have
been present initially, but was microscopic in nature. This is con-
sistent with previous autopsy studies that have shown a hetero-
geneous distribution of sarcoid granulomas in the myocardium [7].
The recent expert consensus document is an excellent resource for
management and risk stratification for cardiac sarcoidosis patients
[8]. ICD implantation for primary prevention is commonly per-
formed due to the high burden of VT events (estimated incidence
rate of 15% per year) in patients with cardiac sarcoidosis [9]. In the
current case, ICD implantation was recommended due to the high
burden of nonsustained VT episodes, left and right ventricular
dysfunction, and the presence of fibrosis and active inflammation
by imaging studies.Conflict of interest
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